Introduction: Hydrocephalus is a common central nervous system disorder in children. In spite of its importance, it has not been subjected to sufficient epidemiological studies, particularly in the developing countries. The aim of this study was to provide information from a representative series of newly diagnosed cases of infantile hydrocephalus on the birth prevalence, associated factors and mortality. Methodology: A prospective study was conducted over a 1-year period from April 1996 to March 1997 in the city of Al-Madinah Al-Munawarah, Saudi Arabia. Except for neural tube defects and brain tumors, all cases of hydrocephalus diagnosed within the first 28 days of life were included. A control group of 104 subjects was studied for comparison. Information about antenatal, natal and early postnatal periods were obtained by interviewing the mothers of the newborns. Results: During the study period, 26 cases of infantile hydrocephalus were detected. The birth prevalence was 1.6 per 1,000 live births. There was no sex preponderance as the male to female ratio was 1.2:1. Multiple pregnancies were detected in 21 (81%) cases. Nineteen (73%) cases were the product of consanguineous parent and 4 patients had a positive family history of hydrocephalus. The number of preterm infants was 16 (62%). The number of low birth weights (less than 2,500 g) was 18 (69%). An Apgar score of less than 8 occurred in 18 (69%) cases. The mode of delivery was vaginal in 15 (58%) women. The 6 months mortality rate was 23% (6 infants). Conclusion: The birth prevalence of infantile hydrocephalus in this study was significantly higher than in the developed countries. A positive family history of hydrocephalus, low birth weight, low Apgar score and abdominal delivery were found to be associated factors. The mortality rate in the first 6 months of life was significantly higher in hydrocephalus infants than in controls.

Keywords:
Epidemiology, Infantile hydrocephalus, Prevalence
1.
Bondurant CP, Jimenez DF: Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg 1995;23:254–259.
2.
Fernell E, Hagberg B, Hagberg G, von Wendt L: Epidemiology of infantile hydrocephalus in Sweden. I. Birth prevalence and general data. Acta Paediatr Scand 1986;75:975–981.
3.
MacMahon B, Pugh TF, Ingalls TH: Anencephalus, Spina bifida and hydrocephalus. Incidence related to sex, race and season of birth, and incidence in siblings. Br J Prev Soc Med 1953;7:211–219.
4.
Gittelsohn AM, Wilham S: Declining incidence of central nervous system anomalies in New York State. Br J Prev Soc Med 1962;16:153–158.
5.
Elwood JH: Secular trends in the incidence of major malformations of the central nervous system. Reported from three Dublin Maternity Hospitals, 1900–1965. Ir J Med Sci 1973;142:346–357.
6.
Haynes SG, Gibson JB, Kurland LT: Epidemiology of neural tube defects and Down’s syndrome in Rochester, Minnesota 1935–1971. Neurology 1974;24:691–700.
7.
Editorial: Epidemiology of anencephalus, spina bifida and congenital hydrocephalus. Br Med J 1976;2(6045):1156.
8.
Kurtzke JF: The geographical distribution of congenital malformations of the neurological system; in Den Hartog J (ed): Neurology. Amsterdam, Excerpta Medica, 1978, pp 375–405.
9.
Stein SC, Feldman JG, Apfel S, Khol SG, Casey G: The epidemiology of congenital hydrocephalus. A study in Brooklyn, New York 1968–1976. Childs Brain 1981;8:253–262.
10.
Granroth G, Hakama M, Saxen L: Defect of the central nervous system in Finland. I. Variations in time and space, sex distributions and parental age. Br J Prev Soc Med 1977;31:164–170.
11.
Spellman MP: A five year survey in Cork of spina bifida and hydrocephaly. J Ir Med Assoc 1970;638:339–342.
12.
Wilson TS: Congenital malformations of the central nervous system among Glasgow births 1964–68. Health Bull (Edinb) 1970;28:32–38.
13.
Weatherall JAC: A review of some effects of recent medical practices in reducing the numbers of children born with congenital abnormalities. Health trends, Department of Helath & Social Security. Welsh Office 1982;14:85–88.
14.
Nakashima S, Watanabe K, Negoro T, Aoki K, Kikuchi H: Clinico-epidemiological features of infantile hydrocephalus in Japan. Acta Paediatr Jap 1996;38:567–575.
15.
Laurence KM, Carter CO, David PA: Major central nervous system malformations in South Wales. Br J Prev Soc Med 1967;21:146–160.
16.
Lorber J: The family history of uncomplicated congenital hydrocephalus: An epidemiological study based on 270 probands. BMJ 1984;289:281–284.
17.
Stoll C, Alembik Y, Dott B, Roth MP: An epidemiologic study of environmental and genetic factors in congenital hydrocephalus. Eur J Epidemiol 1992;8:797–803.
18.
Varadi V, Toth Z, Torok O, Papp Z: Heterogenity and recurrence associated for congenital hydrocephalus (ventriculomegaly): A prospective study. Am J Med Genet 1988;8:305–310.
19.
Fernell E, Hagberg B, Hagberg G, von Wendt L: Epidemiology of infantile hydrocephalus in Sweden. III. Origin in preterm infants. Acta Paediatr Scand 1987;76:418–423.
20.
Marks JD, Khoshnood B: Epidemiology of common neurosurgical diseases in the neonate. Neurosurg Clin North Am 1998;9:63–72.
21.
Ment LR, Oh W, Philip AG, et al: Associated factors for early intraventricular hemorrhage in low birth weight infants. J Pediatr 1992;121:776–783.
22.
Ment LR, Oh W, Ehrenkranz RA, Philip AG, Duncan CC, Makuch RW: Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol 1995;172:795–800.
23.
Shaver DC, Bada HS, Korones SB, Anderson GD, Wong SP, Arheart KL: Early and late intraventricular hemorrhage: The role of obstetric factors. Obstet Gynecol 1992;80:831–837.
24.
Feige A, Douros A: Mortality and morbidity of small premature infants (<1,500 g) in relation to presentation and delivery mode. Z Geburtshilfe Neonatol 1996;200:50–55.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.